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Background: Skin-sparing mastectomy (SSM) and latissimus dorsi (LD) flap immediate breast reconstruction (IBR) is
a tailored surgical procedure. The surgical and patient-reported outcome (PRO) of SSM and LD IBR were assessed.
Methods: Retrospective data of 146 SSMs performed by a single surgeon was reviewed. Among patients included
in the data, 65 patients underwent SSM and LD IBR without a prosthetic implant. A survey estimating the degree of
patient satisfaction (poor, fair, good, and excellent) as regards the cosmetic outcomes of surgery was performed.
The patients were divided into two groups according to their degree of satisfaction (excellent group versus
non- excellent group), and analysis was done to identify factors affecting the highest patient satisfaction.
Results: The mean age of the patients was 48.4 years, and pathological results were: infiltrating ductal carcinoma
(n = 48, 73.8%), ductal carcinoma in situ (n = 15, 23.1%), and others (n = 2, 3.1%). One patient received
postmastectomy radiotherapy. After a mean follow-up of 34 months, no local recurrence occurred. There was no
skin necrosis or LD flap loss. Donor site morbidities were seroma (n = 8, 12.3%), scarring (n = 8, 12.3%), and back
pain (n = 6, 9.2%). Fifty patients (76.9%) were satisfied and 40% reported their degree of satisfaction as excellent.
Breast symmetry (P <0.001), nipple cosmesis (P <0.001), visual difference of bilateral breasts (P = 0.021), and panel
assessment score (P <0.001) were factors that affected the highest patient satisfaction.
Conclusions: Our SSM and LD IBR was safe, with no local recurrence and low morbidities, and produced a
sufficiently high level of patient satisfaction. Achieving breast symmetry and nipple cosmesis would be the key to
meeting the patient’s expectation.
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The fundamental goal in surgical management of breast
cancer is to achieve local control and to provide infor-
mation for planning adjuvant local and systemic therapy.
Over the past decades, surgical management of breast
cancer has evolved from radical mastectomy to breast-
conserving surgery. And most recently, the concept of* Correspondence: min@sch.ac.kr
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reproduction in any medium, provided the orsurgical management is the pursuit of tailored breast
surgery to achieve oncological safety and maximal aes-
thetic results together as the patient-reported outcome
(PRO) has emerged as another fundamental goal.
Skin-sparing mastectomy (SSM), first introduced in
1991 [1,2], refers to a mastectomy which involves en-bloc
removal of all breast tissue and nipple-areola complex
while preserving the native breast skin and the infra-
mammary fold. The adjacent biopsy scar, and skin over-
lying the superficial tumor could also be excised [3].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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with autologous tissue can be achieved utilizing options
such as latissimus dorsi (LD) myocutaneous flap (with or
without prosthetic implant) and transverse rectus abdom-
inis myocutaneous (TRAM) flap. Immediate LD flap recon-
struction without prosthetic implant is the most common
sequence after SSM at our institution, since Korean breast
cancer patients generally have small to moderately-sized
breasts. Compared to delayed breast reconstruction, IBR is
beneficial in relieving psychological trauma to the patient
by restoring the breast mound after operation, and allowing
fewer hospital admissions and operations with concomitant
anesthesia. Also, the oncological safety of SSM with IBR
has been demonstrated in the literature [3-8].
One of the most important issues after SSM and IBR,
along with the oncological safety, might be the PRO of the
surgical procedure. The aim of present study was to esti-
mate the degree of patient satisfaction of SSM and LD IBR
and surgical outcomes as regards to safety, post-operative
complications/morbidities, and aesthetic results. To the
best of our knowledge, this is one of the largest series of
data for breast reconstruction after SSM, using LD flap
without prosthetic implant, reported in the literature.
Methods
Patient selection
A total of 145 consecutive patients underwent SSM at our
institution from March 2000 to March 2011. Patients with
indications for mastectomy with no skin involvement were
offered SSM. In our series, stage 0 to IIIA (Tis to T2, N0
to N2) breast cancer patients, according to the American
Joint Committee on Cancer (AJCC) TNM staging system
were included. All 145 patients received IBR after SSM,
and one patient had bilateral SSM and IBR due to bilateral
breast cancer. The standard operative procedures were
performed by the most senior surgeon in cooperation with
a plastic surgeon. A survey estimating the degree of pa-
tient satisfaction after surgery (poor, fair, good, and excel-
lent) was performed at post-operative follow-ups (range,
1.6 to 89.9 months). Among 85 patients (58.6%) who were
eligible for questionnaire survey, 65 patients (76.5%) had
LD flap reconstruction, 11 (12.9%) had LD flap recon-
struction with prosthetic implant, and 9 (10.6%) had
TRAM flap reconstruction. Sixty-five patients who under-
went SSM and LD IBR without prosthetic implant were
included in the analysis. Written informed consent was
obtained from the patients for publication of this report
and any accompanying images.
Surgical procedure
SSM was performed using a circum-areolar incision
(Figure 1a) in the majority of our cases, and overlying
skin was excised when the tumor was close to the skin.
The infra-mammary fold was preserved. Sentinel lymphnode (SLN) biopsy was done through a separate axillary
incision, and axillary lymph node dissection was per-
formed when an intra-operative frozen section of the
SLN showed presence of malignancy. Attention was paid
to identifying and dissecting the superficial layer of
the superficial fascia (Figure 1b, 1c). After SSM, the
thoracodorsal vessels were identified, and the anterior
portion of the LD muscle was identified and dissected
through an anterior approach. Then the patient was
repositioned in the lateral decubitus position for LD flap
harvest, and skin incision was made at the back within
the brassière line. The LD flap was elevated, rotated on
the thoracodorsal neurovascular pedicle, and then was
transferred subcutaneously to the mastectomy defect
(Figure 1d). Closed suction drains were left at the LD
donor site, mastectomy defect and axilla.Assessment of surgical outcomes
A patient survey was performed on follow-up visits at out-
patient clinic. The degree of patient satisfaction regarding
surgical outcomes was assessed using a questionnaire in-
cluding an analogue scale ranged from 1 to 10 (Figure 2).
None of the patients gave their score as 1 or 2, hence, the
degree of patient satisfaction was determined as poor
(score 3 to 4), fair (score 5 to 6), good (score 7 to 8), and
excellent (score 9 to 10), according to the Harris cosmetic
scale [9].
Surgical outcomes in terms of post-operative compli-
cations including hematoma, infection, scarring, dorsal
seroma, skin necrosis, back pain, and aesthetic outcomes
such as breast symmetry, visual difference of bilateral
breasts, breast contour, and nipple cosmesis were
assessed by a panel of two judges (operating surgeon
and breast clinic nurse).
The patients were divided into two groups according
to their degree of satisfaction. Group 1 was patients with
non-excellent satisfaction (poor, fair, and good), and
group 2 was patients with excellent satisfaction. The
clinico-pathological characteristics, surgical outcomes,
and aesthetic results were compared between the two
groups. An analysis to determine factors affecting the
highest patient satisfaction was performed.Data analysis
All statistical analyses were performed using SPSS
software (SPSS, version 15.0, Chicago, IL, USA). Student’s
t-test was used to compare the means of continuous vari-
ables, and chi-squared test and Fisher’s exact test were
used for univariate comparison of categorical variables.
Pearson’s simple correlation test was used to evaluate the
inter-rater associations. All P-values were two-sided, and
P <0.05 was considered significant.
Figure 1 A 44 year-old woman diagnosed with stage IIA breast cancer of the left breast received skin-sparing mastectomy and
immediate latissimus dorsi myocutaneous flap reconstruction: (a) circum-areolar skin incision, (b) dissection at the superficial layer of
the superficial fascia, the blue arrow indicates dissection plane, (c) mastectomy specimen, (d) transferred latissimus dorsi flap through
a subcutaneous tunnel.
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Patients and clinico-pathological characteristics
A total of 65 patients underwent SSM and LD IBR with-
out prosthetic implant. The mean age of the patients was
48.4 years (range, 21 to 74), and pathological results were:
infiltrating ductal carcinoma in 48 patients (73.8%), ductal
carcinoma in situ in 15 (23.1%), and infiltrating lobular
carcinoma in 2 (3.1%). The mean tumor size was 20 mm
(range, 2 to 48 mm). One patient (1.5%) who had 4 axil-
lary lymph node metastases (N2) received post mastec-
tomy radiotherapy, and 29 patients (44.6%) received
adjuvant chemotherapy including cyclophosphamide,
methotraxate, and fluorouracil (n = 16); fluorouracil,
doxorubicin, and cyclophosphamide (n = 4); doxorubicin,
cyclophosphamide followed by docetaxel (n = 9). Fifteen
patients (23.1%) received anti-hormonal therapy. After a
mean follow-up period of 34 months (range, 1.6 to 89.9
months), none of the patients developed local recurrence.
Only 1 patient (1.5%) developed an axillary metastasis,
and the overall patient survival was 100%. The two patient
groups were similar as regards to age, stage distribution,
tumor histology, and clinical characteristics (Table 1).Post-operative complications and morbidities
The post-operative complications and morbidities were
assessed (Table 2). The incidence of hematoma, wound
infection, and skin flap necrosis/loss was 0%, 0%, and 0%,
respectively. Donor site morbidities occurred in 22 cases;
dorsal seroma in eight (12.3%), marked scarring in eight
(12.3%), and back pain in six (9.2%). Dorsal seroma was
defined as any fluid collection requiring aspiration after
surgery which was managed with repeated percutaneous
aspiration or placement of a closed suction drain. The type
and frequency of complications and morbidities did not
differ significantly between the two groups.
Aesthetic results and patient satisfaction
Nipple reconstruction was performed in 30 patients
(46.2%) using the trefoil local flap technique (Figure 2c).
Three patients (4.6%) had contralateral reduction
mammoplasty as a balancing procedure. Mean donor site
scar length was 17 cm (range, 7 to 24) (Figure 2d).
A senior operating surgeon and the breast clinic
nurse separately assessed the aesthetic outcomes as
regards breast symmetry, visual difference of bilateral
Figure 2 A 56 year-old woman with ductal carcinoma in situ received left skin-sparing mastectomy and immediate latissimus dorsi
myocutaneous flap reconstruction without an implant. Satisfaction score of the patient was 10, which was considered excellent (a)
preoperative state, (b) post-operative state without nipple reconstruction, (c) post-nipple reconstruction state, (d) back scar.
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graded the score from 1 to 10, with 10 being the
best. The mean score was 7.7 (range, 3 to 10) by the
surgeon, and 7.9 (range, 3 to 10) by the breast clinic
nurse. The mean score was 7.6 (range, 3 to 10) by
the patients, which was considered good. Fifty patients
(76.9%) were satisfied with their surgical outcome, and
26 (40%) gave their degree of satisfaction as excellent
(score 9 to 10). No significant difference was seen in the
type of skin incision, contralateral balancing procedure,
nipple reconstruction, and donor site scar length be-
tween the two groups. As for the aesthetic results,
breast size symmetry (P <0.001), visual difference of
bilateral breasts (P = 0.021), nipple cosmesis (P <0.001),
surgeon’s assessment (P <0.001), and breast clinic
nurse’s assessment (P <0.001) were factors that signifi-
cantly affected the excellent outcome for patient satis-
faction (Table 3). Although the assessments of aesthetic
outcome between the surgeon and the breast clinic
nurse showed a significant correlation (0.917, P <0.001),
their assessments did not accord with the degree of
patient satisfaction (Figure 3).Discussion
Our SSM and LD IBR without a prosthetic implant
achieved a high level of patient satisfaction along with
low complication rates. The procedure was safe, and
none of our patients developed local recurrence.
SSM has been demonstrated as an oncologically safe
procedure in patients with early stage breast cancer
[10,11], and in selected patients with locally advanced
breast cancer [5,12,13]. Local recurrence rate after SSM
was reported as 3 to 12% [4]. Although concerns regard-
ing local control and appropriate indications were raised
[14], the available data do not support an increase in the
risk of local recurrence with SSM when an accurate sur-
gical dissection is performed [3,5,6]; and recently, in a
meta-analysis of nine studies comprising 3,739 patients
[4], no significant difference in local recurrence was
noted between 1,104 patients with SSM and IBR, and
2,635 patients with conventional mastectomies without
reconstruction. Most of our series included patients with
early-stage breast cancer, and only one patient (1.5%)
had locally advanced breast cancer. The local recurrence
rate after a mean follow-up period of 34 months was 0%.






















Infiltrating ductal carcinoma 29 (74.4) 19 (73.1)
Ductal carcinoma in situ 8 (20.5) 7 (26.9)
Infiltrating lobular carcinoma 2 (5.1) 0






0 8 (20.5) 7 (26.9)
I 16 (41.0) 13 (50.0)
IIA 10 (25.6) 3 (11.5)
IIB 4 (10.3) 3 (11.5)
IIIA 1 (2.6) 0
T 0.493
Tis 8 (20.5) 7 (26.9)
T1 17 (43.6) 13 (50.0)
T2 14 (35.9) 6 (23.1)
N 0.489
N0 32 (82.0) 23 (88.5)
N1 6 (15.4) 3 (11.5)
N2 1 (2.6) 0
Adjuvant chemotherapy 0.441
No 18 (46.2) 18 (69.2)
CMFa 12 (30.8) 4 (15.4)
AC-Tb 3 (7.7) 1 (3.8)
TACc 3 (7.7) 2 (7.7)
FACd 3 (7.7) 1 (3.8)
Anti-hormone therapy 0.548
No 8 (20.5) 7 (26.9)
Yes 31 (79.5) 19 (73.1)
Radiotherapy 0.411
No 38 (97.4) 26 (100)
Yes 1 (2.6) 0
Local recurrence
No 39 (100) 26 (100)
Yes 0 0
Regional Metastasis 0.411
No 38 (97.4) 26 (100)
Yes 1 (2.6) 0
aCMF:cyclophosphamide, methotraxate, flurouracil; bA, doxorubicin; C,
cyclophosphamide; T, docetaxel; cT, docetaxel, A, doxorubicin, C,
cyclophosphamide; dFAC: flurouracil, epirubicin, cyclophosphamide.
Table 2 Post-operative complications and morbidities
Group 1 (n = 39) Group 2 (n = 26) P-value
Hematoma 0 0
Wound infection 0 0
Flap complication
Skin necrosis 0 0
Fat necrosis 0 0
Flap loss 0 0
Donor site morbidity
Seroma 6 (15.4%) 2 (7.7%) 0.355
Scarring 4 (10.3%) 4 (15.4%) 0.538
Back pain 4 (10.3%) 2 (7.7%) 0.726
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cer developed an axillary metastasis and this occurred
84 months after operation. The patient received doce-
taxel and doxorubicin-based chemotherapy followed by
radiation therapy, and remained safe without any evi-
dence of disease progression at current follow-up.
Post-operative complications could compromise the aes-
thetic outcomes as well as the patient satisfaction. A recog-
nized complication after SSM is skin flap necrosis reported
to occur in 11% [15]. However, there was no case of skin
flap necrosis or flap loss in our series. Accurate dissection
of the superficial layer of the superficial fascia could have
contributed to the enhanced surgical outcomes.
IBR after SSM has a virtue of producing pleasing aes-
thetic results. Since the breast skin is maximally preserved,
IBR using the native skin envelope could be performed to
achieve an optimal aesthetic result through a single-stage
procedure. IBR can reduce the need for a contralateral
balancing procedure to achieve breast symmetry [3,16].
Likewise, only three patients (4.6%) in our series received
a contralateral balancing procedure. Alongside the super-
ior aesthetic outcomes, IBR showed reduced psychological
trauma to the patient, convenience of the operation, cost
benefit, and patient safety [17].
Furthermore, IBR was reported to be oncologically safe
[3-8], and not to result in delay or interference with the
initiation of adjuvant chemotherapy [18]. A study of 166
patients by Caffo et al. [19] reported no marked increase
in the rate of surgical complications due to adjuvant
chemotherapy. Also in our series, none of the patients
had to delay adjuvant chemotherapy after LD IBR.
Autologous LD myocutaneous flap has become a
popular option for breast reconstruction since its intro-
duction in the late 1970s [20,21]. Almost any patient
could be a potential candidate for LD flap due to its
robust blood supply [22,23], and ischemic complications
after LD flap reconstruction are lower compared to
other types of autologous flap reconstruction. Moreover,
LD flap has produced a high level of patient satisfaction
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omy to SSM or nipple-sparing mastectomy [24-26].
Rosson and colleagues [27] identified patients with
small to moderately-sized breasts, inadequate amounts
of abdominal tissue, or a history of previous abdominal
surgery as ideal candidates for LD flap reconstruction.
For most Korean women with a low to normal body
mass index and small to moderately-sized breasts, LD
flap could provide sufficient volume for breast recon-
struction. And since a high proportion of Korean breast
cancer patients are at child-bearing age [28], LD flap is
an attractive option for Korean breast cancer patients.A drawback of LD flap reconstruction is frequent
formation of seroma at LD donor site, reported as 12 to
21% [29,30]. Dorsal seroma was managed with a pro-
longed suction drainage or repeated percutaneous aspir-
ation at the outpatient clinic. Dorsal seroma occurred in
eight patients (12.3%) in our series, which was lower than
other reports. The lower morbidity rate, however, was
not significantly related to higher patient satisfaction.
PRO of breast reconstruction has become increasingly
important in clinical research. Although traditional surgi-
cal outcomes focused on morbidity and mortality as
important measure, they are no longer sufficient on their
own. Patient satisfaction and quality of life has become a
crucial concern. In the present study, 50 patients (76.9%)
were satisfied (good and excellent) with the surgical out-
comes, and 40% reported their degree of satisfaction as
excellent (score 9 to 10), demonstrating SSM and LD IBR
without an implant could produce sufficiently satisfac-
tory results. However, contrary to our expectations, the
type of skin incision, breast contour, and donor site scar
length did not significantly contribute to excellent patient
satisfaction. The breast size symmetry (P <0.001), visual
difference of bilateral breasts (P = 0.021), and the nipple
cosmesis (P <0.001) related to the highest patient satis-
faction, and 53.8% of patients who did not report their
degree of satisfaction as excellent, cited asymmetry as
one of the main reasons. Studies [24,31,32] suggested
that achievement of breast symmetry was the main factor
for patient aesthetic satisfaction after breast reconstruc-
tion. We fully agree and again have confirmed the im-
portance of achieving breast symmetry in our series.
Thirty-five patients (53.8%) did not receive nipple recon-
struction. The reasons for not doing nipple reconstruction
were: fear of the second operation (n = 16, 45.7%); lack of
necessity of the nipple (n = 7, 20%); premature time for nip-
ple reconstruction (n = 8, 22.8%); and others (n = 4, 11.4%).
Nipple cosmesis was the factor that significantly related to
the highest patient satisfaction (P <0.001). Taken together,
these results suggest that immediate nipple reconstruction
at the time of IBR could be another potential factor that
possibly enhances patient satisfaction.
Assessment by the surgeon (P <0.001) and the breast
clinic nurse (P <0.001) were factors affecting the highest
patient satisfaction, and the average score among the three
groups (surgeon, breast clinic nurse, and patient) showed
similar results (7.7, 7.9, and 7.6). The assessment between
surgeon and breast clinic nurse showed a significant cor-
relation (0.917, P <0.001), however, each of them did not
accord with the degree of patient satisfaction (Figure 3).
The authors could not identify confounding factors to
explain the reason. Probably, minor discrepancies could
have existed between patient’s subjective satisfaction and
objective assessment by a third party assessor. Because
expression of patient satisfaction is related both to the
Figure 3 Although the assessments of aesthetic results between surgeon and the breast clinic nurse showed a significant correlation
(0.917, P <0.001, Figure 3a), each result did not accord with the degree of patient satisfaction (Figure 3b, Figure 3c).
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breast reconstruction, patient-reported satisfaction could
not be fully explained by only considering objective assess-
ment measures made by others.
A limitation of the study was the assessment of patient
satisfaction regarding surgical and aesthetic outcomes,
which was measured only by an analogue scale, and hence
the measure used to assess patient quality of life was insuf-
ficient. A structured questionnaire including subscales and
long term satisfaction might be needed to more objectively
assess patient satisfaction. It is also acknowledged that this
study is limited by its small sample size and retrospective
study design. Also, we believe that a uniform period of
assessment after operation, and serial long term follow-up
of patient satisfaction data will be able to provide more
reliable results. The results of this study, however, highlight
low rates of surgical complication as well as high degree of
patient satisfaction following SSM and LD IBR without a
prosthetic implant. Larger standardized measures focusing
on improving PRO as related to aesthetic outcomes are
needed in the future.Conclusions
The present study demonstrated that our SSM and LD
IBR was safe with no local recurrence, and was associated
with a high level of patient satisfaction. LD flap per se,
without a prosthetic implant, could provide enough vol-
ume for breast reconstruction after SSM, with low rates of
morbidities. In circumstances that postmastectomy radio-
therapy is not expected to be required, accurate surgical
technique and careful patient selection could provide a
high level of patient satisfaction and superior aesthetic
results after breast reconstruction.
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